期刊文献+

Gene expression changes in patients with fulminant type 1 diabetes 被引量:3

Gene expression changes in patients with fulminant type 1 diabetes
原文传递
导出
摘要 Background Fulminant type 1 diabetes (F1D) is a complex disease. Microarray analysis was used to identify gene expression changes and obtain understanding of the underlying mechanisms. Methods Microarray analysis was performed on peripheral blood mononuclear cells from six F1D patients and six matched healthy subjects. Real-time polymerase chain reaction was used to verify the differentially expressed genes. NK cell activity was detected by methyl thiazoleterazolium assay. Results Microarray analysis identified 759 genes differing in expression between F1D patients and controls at a false discovery rate of 0.05. Expression of TLR9, ELF4 and ILIRAP were verified and consistent with changes in microarray results. NK cell activity was decreased in FID. With use of a knowledge base, differentially expressed genes could be placed within different pathways with predicted functions including interleukin-1, and tumor necrosis factor-a signaling. Conclusions These results identify several genes indicating possible mechanisms in FID. NK cell dysfunction resulting from changes in expression of TLR9, ELF4 and IL1RAP, and pathways of interleukin-1 and tumor necrosis factor-a sianalino miaht be involved in F1D throuoh inducino B-cell dysfunction. Background Fulminant type 1 diabetes (F1D) is a complex disease. Microarray analysis was used to identify gene expression changes and obtain understanding of the underlying mechanisms. Methods Microarray analysis was performed on peripheral blood mononuclear cells from six F1D patients and six matched healthy subjects. Real-time polymerase chain reaction was used to verify the differentially expressed genes. NK cell activity was detected by methyl thiazoleterazolium assay. Results Microarray analysis identified 759 genes differing in expression between F1D patients and controls at a false discovery rate of 0.05. Expression of TLR9, ELF4 and ILIRAP were verified and consistent with changes in microarray results. NK cell activity was decreased in FID. With use of a knowledge base, differentially expressed genes could be placed within different pathways with predicted functions including interleukin-1, and tumor necrosis factor-a signaling. Conclusions These results identify several genes indicating possible mechanisms in FID. NK cell dysfunction resulting from changes in expression of TLR9, ELF4 and IL1RAP, and pathways of interleukin-1 and tumor necrosis factor-a sianalino miaht be involved in F1D throuoh inducino B-cell dysfunction.
机构地区 Diabetes Center
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第22期3613-3617,共5页 中华医学杂志(英文版)
基金 This work was supported by grants from the National Natural Science Foundation of China (No. 81170725, 81070672, 81000316), the European Foundation for the Study of Diabetes (No. EFSD/CDS/Lilly-2010), the Key Project of Science and Technology Department of Hunan Province of China (No. 2010SK2007), Hunan Provincial Natural Science Foundation of China (No. 11JJ7005), the National Department Public Benefit (Health) Research Foundation of China (No. 201002002), Research Fund for the Doctoral Program of Higher Education of China (No. 200805331018). There are no financial/commercial conflicts of interests involving in this study.
关键词 fulminant type 1 diabetes peripheral blood mononuclear cells gene expression profile fulminant type 1 diabetes, peripheral blood mononuclear cells, gene expression profile
  • 相关文献

参考文献19

  • 1Imagawa A,Hanafusa T,Miyagawa J,Matsuzawa Y.A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.Osaka IDDM Study Group.N Engl J Med 2000; 342:301-307.
  • 2Tanaka S,koboyashi T,Mototsu T.A novel subtype of type 1 diabetes mellitus.N Engl J Med 2000; 342:1835-1837.
  • 3Shimabukuro M,Koyama K,Lee Y,Unger RH.Leptin-or troglitazone-induced lipopenia protects islets from intefleukin 1β cytotoxicity.J Clin Invest 1997; 100:1750-1754.
  • 4Kent SC,Chen Y,Clemmings SM,Viglietta V,Kenyon NS,Ricordi C,et al.Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells.J Immunol 2005; 175:4458-4464.
  • 5Ott PA,Berner BR,Herzog BA,Guerkov R,Yonkers NL,Durinovic-Bello I,et al.CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases.J Immunol 2004; 285:223-235.
  • 6Ellen CK,Casey LG,Damien C,Banchereau J,Pascual V,White PC.Gene expression in peripheral blood mononuclear cells from children with diabetes.J Clin Endocrinol Metab 2007; 92:3705-3711.
  • 7Melanie R,Adolpho M,de Oliveira JE.NK calls and type 1 diabetes.Clin Dev Immunol 2006; 13:101-107.
  • 8Sarkar S A,Kutlu K,Velmurugan S,Kizaka-Kondoh S,Lee CE,Wong R,et al.Cytokine mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line.Diabetologia 2009; 52:1092-1101.
  • 9Sundar SK,Becker KJ,Cierpial MA,Carpenter MD,Rankin LA,Fleener SL,et al.Intracerebroventricular infusion of interleukin-1 rapidly decreases peripheral cellular immune responses.Proc Natl Acad Sci 1989; 86:6398-6402.
  • 10Wesche HC,Korherr M,Kracht W,Falk W,Resch K,Martin MU.The interleukin-1 receptor accessory protein (IL-lRAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stressactivated protein kinases (SAP kinases).J Biol Chem 1997; 272:7727-7731.

同被引文献4

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部